| # | Drug | Count |
|---|---|---|
| 0 | BORTEZOMIB | 3 |
| 1 | CILTACABTAGENE AUTOLEUCEL | 3 |
| 2 | LENALIDOMIDE | 3 |
| 3 | METHOTREXATE SODIUM | 3 |
| 4 | ABATACEPT | 2 |
| 5 | BISOPROLOL FUMARATE | 2 |
| 6 | DIVALPROEX SODIUM | 2 |
| 7 | FUROSEMIDE | 2 |
| 8 | IRBESARTAN | 2 |
| 9 | LANSOPRAZOLE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CILTACABTAGENE AUTOLEUCEL | 3 | 0.0005 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 2 | IRBESARTAN | 2 | 0.0000 |
| 3 | DIVALPROEX SODIUM | 2 | 0.0000 |
| 4 | METHYLPREDNISOLONE SODIUM SUCCINATE | 2 | 0.0000 |
| 5 | BORTEZOMIB | 3 | 0.0000 |
| 6 | OLANZAPINE | 2 | 0.0000 |
| 7 | MIRABEGRON | 1 | 0.0000 |
| 8 | NIVOLUMAB | 2 | 0.0000 |
| 9 | BISOPROLOL FUMARATE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Proteasome Inhibitor [EPC] | 3 | 0.0000 |
| 1 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 2 | 0.0000 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 2 | 0.0000 |
| 5 | Thalidomide Analog [EPC] | 3 | 0.0000 |
| 6 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 2 | 0.0000 |
| 9 | Loop Diuretic [EPC] | 2 | 0.0000 |